Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding calibration revenue trends or ISO/IEC 17025 compliance costs inside a Transcat Inc 10-K can feel like hunting through a maze of metrology jargon. Investors want the numbers, not another technical manual. Stock Titan’s platform meets that need head-on: understanding Transcat SEC documents with AI means our algorithms read every footnote and surface what matters in seconds.
Below, you’ll see every filing the moment it hits EDGAR, but raw documents are only half the story. Our AI-powered summaries translate dense disclosures into clear takeaways and link directly to the page, table or exhibit where the data lives. Whether you’re tracking laboratory acquisitions or distribution margins, the forms are mapped to investor questions:
- Form 10-K: The Transcat annual report 10-K simplified highlights service-versus-distribution revenue, calibration backlog and risk factors.
- Form 10-Q: The Transcat quarterly earnings report 10-Q filing pairs AI charts with our Transcat earnings report filing analysis so you can compare margins quarter over quarter.
- Form 4: Real-time alerts for Transcat insider trading Form 4 transactions and Transcat Form 4 insider transactions real-time show when executives buy or sell shares; each Transcat executive stock transactions Form 4 is tagged for context.
- Form 8-K: From new ISO-accredited lab openings to bolt-on acquisitions, see Transcat 8-K material events explained in plain English.
- DEF 14A: The Transcat proxy statement executive compensation breaks down pay tied to calibration service growth.
Because every Transcat filing is tagged, cross-referenced and summarized, you can monitor segment expansion, capital expenditure on new calibration labs or shifts in inventory within minutes—no spreadsheets required. Consider Stock Titan your always-awake analyst: real-time filing updates, expert commentary and AI-powered comparisons across years mean Transcat SEC filings explained simply. Make decisions faster, backed by the complete regulatory record.
Robert Mecca, a director of Transcat Inc. (TRNS), reported equity award activity on 09/10/2025 and 09/11/2025. On 09/10/2025 the filing shows restricted stock units (RSUs) granted totaling 1,587 RSUs that convert one-for-one into common stock and, per the award terms, generally vest on September 10, 2026. On 09/11/2025 a separate tranche of 704 RSUs is reported as vested, converting into common stock. The filing also discloses a stock option covering 10,000 shares with an exercise price of $98.88 and an expiration date of January 24, 2034; this option vests pro rata over five years. The form is signed by an attorney-in-fact on behalf of Mr. Mecca on September 11, 2025. The disclosure is limited to these award and vesting events and does not include earnings, cash transactions, or other operational details.
Transcat Inc. (TRNS) director Mbago M. Kaniki received equity awards and holds an option position. The filing reports conversion-eligible restricted stock units (RSUs) that convert one-for-one into common stock. RSUs granted 09/10/2025 total 1,587 shares and vest on 09/10/2026. An additional 704 RSUs vested and converted on 09/11/2025, increasing beneficial ownership by 704 shares. The reporting person also holds a stock option to buy 10,000 shares at $47.14 per share exercisable on a pro rata vesting schedule through 05/12/2031. After the reported transactions, the filer directly beneficially owns 2,593 shares.
Gary J. Haseley, a director of Transcat Inc. (TRNS), reported equity changes arising from restricted stock unit (RSU) activity in September 2025. On September 11, 2025 704 shares were acquired following RSU vesting at no cash cost. Following that transaction, Mr. Haseley held 39,102 shares directly. The filing also shows 1,200 shares held indirectly through family trusts.
Separately, on September 10, 2025 he received an award of 1,587 RSUs granted under a Rule 16b-3 exempt transaction; those RSUs vest on September 10, 2026 and convert one-for-one to common stock when vested. The filing is a routine Section 16 disclosure documenting vesting and a new RSU grant.
Christopher P. Gillette, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership on Form 4. The filing shows 704 shares were acquired on 09/11/2025 through the vesting of restricted stock units (RSUs) and are reported with a $0 per-share conversion value. The document also discloses an earlier RSU grant of 1,587 RSUs dated 09/10/2025 that convert one-for-one to common stock and generally vest on 09/10/2026. In addition, Mr. Gillette holds a stock option covering 10,000 shares with an exercise price of $109.55 and pro rata vesting over five years. The filing was signed by an attorney-in-fact on behalf of Mr. Gillette on 09/11/2025.
Reporting person: Dawn DePerrior, a director of Transcat, Inc. (TRNS). The Form 4 discloses equity awards and option activity reported for transactions on September 10-11, 2025. On 09/10/2025 Ms. DePerrior was awarded 1,587 restricted stock units (RSUs) that convert one-for-one into common shares and vest on 09/10/2026. On 09/11/2025 704 RSUs vested and converted into 704 shares of common stock, increasing her beneficial ownership by that amount. Also reported is a stock option to purchase 10,000 shares at an exercise price of $92.92 that vests pro rata over five years from the grant date and expires 10/26/2033. All reported holdings are direct.
Transcat Inc (TRNS) director Oksana S. Dominach reported equity transactions on Form 4 reflecting restricted stock unit (RSU) activity and an outstanding stock option. On 09/11/2025, 704 RSUs were reported as acquired under transaction code M and converted into common stock at no cash price; 1,587 RSUs were reported as acquired on 09/10/2025 but vest on 09/10/2026 per the award terms. The filing also shows a fully vested stock option to purchase 10,000 shares at $26.27 expiring 10/22/2029. Following the reported transactions, Dominach beneficially owns 4,346 shares.
Craig D. Cairns, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership. The filing shows restricted stock units (RSUs) converting to common stock on a one-for-one basis, with 1,587 RSUs reported as acquired on 09/10/2025 and shown as 1,587 shares beneficially owned directly. An additional 704 RSUs are reported with transaction code M on 09/11/2025. Following the reported transactions, Mr. Cairns directly beneficially owns 5,003 shares of common stock and holds a stock option for 10,000 shares with a $47.14 exercise price exercisable pro rata through 05/12/2031. He also has indirect holdings via the Howe & Rusling 401(k) plan (430 shares) and Roth 401(k) plan (1,910 shares). The filing was signed by an attorney-in-fact on Mr. Cairns' behalf.
Transcat, Inc. (TRNS) reporting person Cynthia Langston, a director, recorded equity award activity on Form 4. On 09/11/2025 Ms. Langston was reported to have acquired 704 shares through vesting or conversion of restricted stock units at $0 per share and continues to beneficially own 1,837 shares of common stock directly after the reported transactions. A prior grant of 1,587 RSUs (granted 09/10/2025) was noted as exempt under Rule 16b-3 and generally vests on 09/10/2026, while 1,587 RSUs vested on 09/10/2025 and converted one-for-one into common shares. Additionally, a stock option covering 10,000 shares with an exercise price of $73.80 and a five-year pro rata vesting schedule was reported.
Kristina L. Johnston, Principal Accounting Officer of Transcat, Inc. (TRNS), reports beneficial ownership of 358 restricted stock units (RSUs) awarded under the Transcat, Inc. 2021 Stock Incentive Plan. Each RSU converts into one share of common stock on a one-for-one basis and, unless noted otherwise in the award, vests on March 25, 2028. The statement indicates direct ownership of these RSUs.